Peregrine Pharmaceuticals announced the appointment of Roger J. Lias, Ph.D., as the company’s new president and chief executive officer.     Dr. Lias, who has more than 20 years of contract development and manufacturing organization (CDMO) management experience, currently sits on the Peregrine board of directors and serves as president of Avid Bioservices, Peregrine’s wholly-owned CDMO subsidiary.   As part of this transformation, Peregrine is actively implementing a multi-pronged strate...